Advertisement

Topics

Mycoses Market: By Types of Fungi dermatophytes, yeasts and molds, others, By Treatment Photodynamic, Radiation, Chemotherapy, Targeted, Others By RegionForecast 20162021 [Updated: 05012016] Prices from USD $5250

10:51 EDT 22 Jun 2017 | BioPortfolio Report Blog

Mycoses surgeries are the root cause of fungal skin infections caused by fungi and primarily caused by three groups of fungi: dermatophytes, yeasts and moldsare. Mycoses are caused due to weakened immune systems, i.e., immunocompromised state that includes patients with HIV/AIDS and patients being treated with corticosteroids for a prolonged period. Globally, increasing prevalence of AIDS/HIV and weakened immune systems, Large Population Base, rising awareness regarding Mycoses, and Recent development in technology are the prime growth drivers of global Mycoses market. In addition, increase in adoption of Mycoses treatment, and emerging economies such as China, India and others, will create new opportunities for global Mycoses market. However, higher cost of the research and development, and risk of side effects are the key restraints for global Mycoses market.



Geographically North America dominated global Mycoses market, with approximately half of the world's procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Europe is projected to have fastest growth, owing to rapidly increasing prevalence AIDS/HIV, leading to weakened commune system, Population's changing life style and environment, and modernization of healthcare infrastructure. Among all the types, Dermatophytes has the highest market share in global Mycoses market due to higher prevalence of low immune patients across the globe.

This report identifies the global Mycoses market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Mycoses market.

This report segments global Mycoses market on the basis of type of fungi, treatment, and regional market as follows:
Mycoses Market, By Type of Fungi: dermatophytes, yeasts and molds, others
The report has focused study on Mycoses market by basis of treatment such as: Photodynamic, Radiation, Chemotherapy, Targeted, Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Mycoses market. Some of the major companies' profiles in detail are as follows:
Bayer AG
Dr. Reddy's Laboratories Limited
Merck Co., Inc
Pacgen Biopharmaceuticals Corporation
Quinnova Pharmaceuticals, Inc

Original Article: Mycoses Market: By Types of Fungi dermatophytes, yeasts and molds, others, By Treatment Photodynamic, Radiation, Chemotherapy, Targeted, Others By RegionForecast 20162021 [Updated: 05012016] Prices from USD $5250

NEXT ARTICLE

More From BioPortfolio on "Mycoses Market: By Types of Fungi dermatophytes, yeasts and molds, others, By Treatment Photodynamic, Radiation, Chemotherapy, Targeted, Others By RegionForecast 20162021 [Updated: 05012016] Prices from USD $5250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...